Cover Image
Market Research Report

Acute Heart Failure Global Clinical Trials Review, H2, 2019

Published by GlobalData Product code 315202
Published Content info 181 Pages
Delivery time: 1-2 business days
Price
Not Available
Back to Top
Acute Heart Failure Global Clinical Trials Review, H2, 2019
Published: December 17, 2019 Content info: 181 Pages

This publication has been discontinued on January 18, 2020.

Description

GlobalData's clinical trial report, "Acute Heart Failure Global Clinical Trials Review, H2, 2019" provides an overview of Acute Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Product Code: GDHC5204CTIDB

Table of Contents

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
  • Top Five Countries Contributing to Clinical Trials in Europe 13
  • Top Countries Contributing to Clinical Trials in North America 14
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
  • Top Five Countries Contributing to Clinical Trials in Central and South America 16
  • Clinical Trials by G7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials 17
  • Clinical Trials by Phase in G7 Countries 19
  • Clinical Trials in G7 Countries by Trial Status 20
  • Clinical Trials by E7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials 21
  • Clinical Trials by Phase in E7 Countries 22
  • Clinical Trials in E7 Countries by Trial Status 23
  • Clinical Trials by Phase 24
  • In Progress Trials by Phase 25
  • Clinical Trials by Trial Status 26
  • Clinical Trials by End Point Status 27
  • Subjects Recruited Over a Period of Time 28
  • Clinical Trials by Sponsor Type 29
  • Prominent Sponsors 30
  • Top Companies Participating in Acute Heart Failure Therapeutics Clinical Trials 32
  • Prominent Drugs 33
  • Latest Clinical Trials News on Acute Heart Failure 34
  • Nov 17, 2019: Interim analysis from EMPRISE real-world study shows empagliflozin decreased risk of hospitalisation for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists 34
  • Nov 13, 2019: Lilly and Boehringer begin study of Jardiance in heart failure 34
  • Oct 25, 2019: Windtree Therapeutics provides business update on istaroxime 35
  • Clinical Trial Profile Snapshots 36

Appendix 186

  • Abbreviations 186
  • Definitions 186
  • Research Methodology 187
  • Secondary Research 187
  • About GlobalData 188
  • Contact Us 188
  • Source 189

List of Tables

  • Acute Heart Failure Therapeutics, Global, Clinical Trials by Region, 2019* 8
  • Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
  • Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
  • Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
  • Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
  • Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
  • Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
  • Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16
  • Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2019* 18
  • Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
  • Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
  • Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2019* 21
  • Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22
  • Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23
  • Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase, 2019* 24
  • Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 25
  • Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2019* 26
  • Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2019* 27
  • Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 28
  • Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 29
  • Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 31
  • Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 32
  • Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 33

List of Figures

  • Acute Heart Failure Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
  • Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
  • Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
  • Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
  • Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
  • Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
  • Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
  • Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16
  • Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2019* 17
  • Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
  • Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
  • Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2019* 21
  • Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22
  • Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23
  • Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2019* 24
  • Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 25
  • Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2019* 26
  • Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2019* 27
  • Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 28
  • Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 29
  • Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 30
  • Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 32
  • Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 33
  • GlobalData Methodology 187
Back to Top